Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

Two decades ago, Professor Shao-Cong Sun first discovered the non-canonical NF-κB pathway mediated by NF-κB-inducing kinase (NIK). Since then, more ...

A woman who died in a vape fire in her cell may have been saved if the prison was fitted with automatic alarms, an inquest ...

Immunome (immune cells and functions) variations are closely related to human health. Various exposures, including the external environment and personal lifestyles, are important factors affecting the ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...

Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in difficult-to-treat cancersMechanisms ...

Most people know only two things about the appendix: You don’t need it – and if it bursts, you need surgery fast. That basic ...

Plants have an immune system, like people, and when it is triggered by threats like disease or pests, a plant’s defenses are activated. But there’s a downside to this protective mechanism: The plant’s ...

Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...